2-oxo-hept-3-ene-1,7-dioate hydratase activity
|
phenotype |
|
Molecular Function
|
14
|
|
0.300 |
strong |
1.000 |
1 |
|
2016 |
2016 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adult Anaplastic Large Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
128
|
2
|
0.060 |
None |
0.833 |
6 |
|
1997 |
2019 |
Adult Leiomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
141
|
1
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Adult Liver Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1377
|
72
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2011 |
Adult Malignant Peripheral Nerve Sheath Tumor
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
62
|
2
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Adult Primary Cutaneous Anaplastic Large Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
12
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adult Rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
509
|
12
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Advanced Renal Cell Carcinoma
|
disease |
|
Neoplastic Process
|
27
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Age related macular degeneration
|
disease |
Eye Diseases
|
Disease or Syndrome
|
685
|
663
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Amblyopia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
85
|
29
|
0.100 |
None |
|
0 |
|
|
|
Anaplasia
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
538
|
7
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Anaplastic Large Cell Lymphoma, ALK-Positive
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
25
|
|
0.020 |
None |
0.500 |
2 |
|
2018 |
2019 |
Anemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
847
|
94
|
0.110 |
None |
1.000 |
1 |
|
2020 |
2020 |
Angiodysplasia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
7
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Angiodysplasia of colon
|
disease |
Digestive System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Angioimmunoblastic Lymphadenopathy
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
109
|
8
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Aortic Aneurysm
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
278
|
19
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Arteriovenous hemangioma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Cardiovascular Diseases
|
Neoplastic Process
|
76
|
14
|
0.100 |
None |
1.000 |
23 |
|
2000 |
2018 |
Arteriovenous malformation of liver
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
2
|
|
0.400 |
strong |
1.000 |
1 |
|
2003 |
2003 |
Arteriovenous Malformations, Cerebral
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Cardiovascular Diseases
|
Congenital Abnormality
|
35
|
6
|
0.130 |
None |
1.000 |
3 |
|
2004 |
2018 |
Associated Pulmonary Arterial Hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
22
|
4
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
Atypical fibroxanthoma of skin
|
disease |
Neoplasms
|
Neoplastic Process
|
27
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |